DK1240310T3 - Fremgangsmåde til inaktivering af mikroorganismer - Google Patents

Fremgangsmåde til inaktivering af mikroorganismer

Info

Publication number
DK1240310T3
DK1240310T3 DK00993526T DK00993526T DK1240310T3 DK 1240310 T3 DK1240310 T3 DK 1240310T3 DK 00993526 T DK00993526 T DK 00993526T DK 00993526 T DK00993526 T DK 00993526T DK 1240310 T3 DK1240310 T3 DK 1240310T3
Authority
DK
Denmark
Prior art keywords
microorganism
inactivant
cross
linking agent
inactivating microorganisms
Prior art date
Application number
DK00993526T
Other languages
Danish (da)
English (en)
Inventor
Simon Johannes Barteling
Original Assignee
Agricultural Research Council
Inst Animal Science And Health
Simon Johannes Barteling
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agricultural Research Council, Inst Animal Science And Health, Simon Johannes Barteling filed Critical Agricultural Research Council
Application granted granted Critical
Publication of DK1240310T3 publication Critical patent/DK1240310T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32161—Methods of inactivation or attenuation
    • C12N2770/32163—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Fertilizers (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK00993526T 1999-12-20 2000-12-18 Fremgangsmåde til inaktivering af mikroorganismer DK1240310T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA997757 1999-12-20
PCT/ZA2000/000254 WO2001046390A2 (en) 1999-12-20 2000-12-18 Method of inactivating microorganisms

Publications (1)

Publication Number Publication Date
DK1240310T3 true DK1240310T3 (da) 2008-05-26

Family

ID=25588046

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00993526T DK1240310T3 (da) 1999-12-20 2000-12-18 Fremgangsmåde til inaktivering af mikroorganismer

Country Status (14)

Country Link
US (1) US6673349B2 (ja)
EP (1) EP1240310B1 (ja)
JP (1) JP2003517834A (ja)
AT (1) ATE384786T1 (ja)
AU (1) AU782907B2 (ja)
BR (1) BR0016563A (ja)
CA (1) CA2394946C (ja)
CY (1) CY1107420T1 (ja)
DE (1) DE60037907T2 (ja)
DK (1) DK1240310T3 (ja)
ES (1) ES2300286T3 (ja)
PT (1) PT1240310E (ja)
TR (1) TR200202104T2 (ja)
WO (1) WO2001046390A2 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1734992T1 (sl) * 2004-01-21 2012-01-31 Merial Ltd Izboljšana inaktivirana FCV cepiva
AU2009327837A1 (en) * 2008-12-19 2011-07-28 Kabushiki Kaisha Saiwai Medical Method for preparing comprehensive anti-surface antibody using microorganism immobilized as antigen with protein crosslinking and immobilization reagent
WO2010144797A2 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Influenza vaccines with enhanced immunogenicity and uses thereof
CN102406931B (zh) * 2011-11-25 2014-02-05 成都康华生物制品有限公司 大流行流感病毒裂解疫苗
CN105056225B (zh) * 2015-07-30 2018-01-16 成都天邦生物制品有限公司 一种灭活疫苗的制备方法
AU2017207076B2 (en) 2016-01-15 2021-04-29 Km Biologics Co., Ltd. Vaccine containing immobilized virus particles
CN114540317A (zh) * 2022-03-17 2022-05-27 新疆方牧生物科技有限公司 一种悬浮培养口蹄病毒灭活的工艺方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1924303A1 (de) 1969-05-13 1970-12-17 Bayer Ag AEthylaethylenimin als Inaktivierungsmittel
US5069901A (en) * 1988-02-03 1991-12-03 Jones Elaine V Preparation of a recombinant subunit vaccine against pseudorabies infection
US5242686A (en) 1990-11-07 1993-09-07 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
GB9110808D0 (en) * 1991-05-17 1991-07-10 Retroscreen Ltd Aids vaccine and method for its production
NZ261992A (en) * 1993-02-08 1996-06-25 Bayer Ag Porcine reproductive and respiratory syndrome virus, cultures, attenuated forms and vaccines thereof
SK95198A3 (en) * 1996-02-23 1999-02-11 Procter & Gamble Disinfecting compositions

Also Published As

Publication number Publication date
CA2394946A1 (en) 2001-06-28
AU2979601A (en) 2001-07-03
JP2003517834A (ja) 2003-06-03
BR0016563A (pt) 2002-09-10
AU782907B2 (en) 2005-09-08
ATE384786T1 (de) 2008-02-15
EP1240310A2 (en) 2002-09-18
TR200202104T2 (tr) 2002-12-23
US6673349B2 (en) 2004-01-06
WO2001046390A2 (en) 2001-06-28
EP1240310B1 (en) 2008-01-23
US20030035811A1 (en) 2003-02-20
CY1107420T1 (el) 2012-12-19
PT1240310E (pt) 2008-05-05
DE60037907D1 (de) 2008-03-13
ES2300286T3 (es) 2008-06-16
DE60037907T2 (de) 2009-07-09
CA2394946C (en) 2010-12-14
WO2001046390A3 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
CY1107420T1 (el) Μεθοδος απενεργοποιησεως μικροοργανισμων
AR055422A2 (es) Composicion de antigeno, composicion de vacuna y procedimiento para tratar un cerdo
DE60226911D1 (de) Entwicklung einer Vakzine zur Prävention von Infektionen mit Filovirus bei Primaten
ATE279469T1 (de) Thermisch härtbare, wässrige zusammensetzungen
ATE426412T1 (de) Adjuvante influenza-vakzine
ES2186809T3 (es) Composiciones de vacunas para administracion intranasal, comprendiendo chitosana y su uso.
DK1121135T3 (da) Præparater af beta-glucaner og specifikke immunglobuliner
DK0915648T3 (da) Fremgangsmåder og præparater til selektiv modificering af nukleinsyrer
ES2244617T3 (es) Vacunas a base de salmonelas en las cuales los genes ssa han sido inactivados.
ATE392216T1 (de) Mycobakterieller impfstoff
DK0550450T3 (da) Anvendelse af tværbundne krystaller som ny fremgangsmåde til immobilisering af enzymer
DK1395283T3 (da) Heterolog beskyttelse induceret ved immunisering med Invaplex-vaccine
DE60124289D1 (de) Verfahren zur herstellung von 21-hydroxy-6,19-oxidoprogesteron (21oh-6op)
ATE456958T1 (de) Mannose als adjuvant für intranasale vakzine
DE69525659D1 (de) Grippe-impfstoff
NL300336I1 (nl) Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
EE200200157A (et) Vaktsiin
ATE246250T1 (de) Immunogenes konstrukt, verfahren zu dessen herstellung und verwendung als vakzine
DE50100698D1 (de) Verfahren zur Herstellung von 1,3,6-Hexantricarbonitril
PT757556E (pt) Bacterina borrelia burgdorferi
ATE343390T1 (de) Kalzilytische verbindungen
AR027030A1 (es) Metodo para la inactivacion de microorganismos
WO2003054176A3 (en) Preparation of vaccines using photosensitizer and light
DE60036705D1 (de) Adjuvanskombinationen zur immunisierung und vakzine
DK1227840T3 (da) Adjuverede, genetiske vacciner